ImmuCell Correlations
| ICCC Stock | USD 6.36 0.06 0.93% |
The current 90-days correlation between ImmuCell and Equillium is -0.06 (i.e., Good diversification). The correlation of ImmuCell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ImmuCell Correlation With Market
Very poor diversification
The correlation between ImmuCell and DJI is 0.89 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ImmuCell and DJI in the same portfolio, assuming nothing else is changed.
Moving together with ImmuCell Stock
| 0.77 | GXEA | Galapagos NV Earnings Call Today | PairCorr |
| 0.61 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.73 | VERA | Vera Therapeutics | PairCorr |
| 0.79 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.84 | DRTS | Alpha Tau Medical | PairCorr |
| 0.83 | 0P6S | Bayer AG NA | PairCorr |
| 0.67 | DVAX | Dynavax Technologies | PairCorr |
Moving against ImmuCell Stock
| 0.71 | OSE | OSE Pharma SA | PairCorr |
| 0.66 | DRMA | Dermata Therapeutics | PairCorr |
| 0.63 | ABNX | Abionyx Pharma SA | PairCorr |
| 0.49 | OB3 | OPTIBIOTIX HLTH PLC | PairCorr |
| 0.49 | VCEL | Vericel Corp Ord Earnings Call This Week | PairCorr |
| 0.47 | RAC | Race Oncology Earnings Call Today | PairCorr |
| 0.45 | VCYT | Veracyte Earnings Call This Week | PairCorr |
| 0.81 | VTGN | VistaGen Therapeutics | PairCorr |
| 0.79 | VSTM | Verastem Sell-off Trend | PairCorr |
| 0.78 | DTIL | Precision BioSciences | PairCorr |
| 0.76 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.73 | CDTTW | Conduit Pharmaceuticals | PairCorr |
| 0.64 | XE9 | Xencor Inc Earnings Call This Week | PairCorr |
| 0.59 | IGS1 | India Globalization | PairCorr |
| 0.58 | VRAX | Virax Biolabs Group | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ImmuCell Stock performing well and ImmuCell Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ImmuCell's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EQ | 4.99 | 0.95 | 0.15 | 0.91 | 5.18 | 18.89 | 43.07 | |||
| CUE | 5.67 | (1.02) | 0.00 | (0.54) | 0.00 | 11.11 | 50.98 | |||
| OTLK | 5.92 | (1.25) | 0.00 | 0.77 | 0.00 | 11.36 | 72.05 | |||
| COEP | 3.44 | (0.39) | 0.00 | (0.12) | 0.00 | 7.91 | 31.89 | |||
| OSTX | 3.19 | (0.69) | 0.00 | (0.35) | 0.00 | 5.56 | 16.39 | |||
| NRXP | 4.25 | (0.45) | 0.00 | (0.20) | 0.00 | 8.06 | 19.22 | |||
| FBIO | 3.53 | 0.30 | 0.09 | 0.19 | 4.15 | 10.11 | 29.21 | |||
| IPSC | 6.47 | 2.61 | 0.38 | 3.96 | 4.75 | 14.71 | 59.27 | |||
| SNTI | 4.71 | (0.83) | 0.00 | (0.34) | 0.00 | 7.73 | 53.50 | |||
| GNTA | 4.29 | (1.03) | 0.00 | (1.58) | 0.00 | 8.70 | 33.85 |
ImmuCell Corporate Executives
Elected by the shareholders, the ImmuCell's board of directors comprises two types of representatives: ImmuCell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ImmuCell. The board's role is to monitor ImmuCell's management team and ensure that shareholders' interests are well served. ImmuCell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ImmuCell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Timothy Fiori | Secretary, CFO | Profile |